Michal Pastorek

680 citations
38 papers · 532 indexed · h-index 15
Topics
Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers)Immune cells in cancer (4 papers)Genomics, phytochemicals, and oxidative stress (3 papers)

In The Last Decade

Michal Pastorek

37 papers receiving 527 citations

Peers

Michal Pastorek
Comparison fields: 5 of 110
  • Molecular Biology 239
  • Immunology 90
  • Materials Chemistry 84
  • Cancer Research 56
  • Oncology 48
Replace A. V. Ulasov with:
A. V. Ulasov Russia
Periklis Pappas Greece
Xingguang Liang China
Mengyao Jin United States
Hang Zhao China
Kun Wu China
Shiwei Zhang China
Guoyong Liu China
Michael R. Weaver United States
Michal Pastorek relative to A. V. Ulasov Russia A. V. Ulasov's profile →
Citations per field
00.5×4.4×
A. V. Ulasov · 1×
Citations per year

Countries citing papers authored by Michal Pastorek

Since Specialization
Citations

This map shows the geographic impact of Michal Pastorek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Pastorek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Pastorek more than expected).

Fields of papers citing papers by Michal Pastorek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Pastorek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Pastorek. The network helps show where Michal Pastorek may publish in the future.

Co-authorship network of co-authors of Michal Pastorek

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Pastorek. A scholar is included among the top collaborators of Michal Pastorek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Pastorek. Michal Pastorek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 3
5 2
6 5
7 11
8 3
9 5
10 1
11 10
12 11
13 9
14 32
15 7
16 14
17 30
18 37
19 51
20 16

About Michal Pastorek

Michal Pastorek is a scholar working on Behavioral Neuroscience, Immunology and Physiology, having authored 38 papers that have together received 532 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Immune cells in cancer (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). The work is most often cited by research in Immunology (90 citations), Cancer Research (56 citations) and Molecular Biology (239 citations). Michal Pastorek has collaborated with scholars based in Slovakia, Czechia and United Kingdom. Frequent co-authors include Dana Cholujová, Ján Sedlák, Peter Celec, Oľga Križanová, Lucia Csáderová, Silvia Pastoreková, Soňa Hudecová, Martin Fábian, Bořivoj Vojtěšek and Zdenka Lukáčová Bujňáková. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026